Skip to content

Pomgnt1 Related Disorder Cn239299

Published: July 22, 2026Updated: August 20, 2026

A genetic condition causing muscle weakness and developmental delays from birth. Management focuses on supportive care and physical therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Respiratory failure

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Motor delay

(musculoskeletal)

Muscle weakness

(musculoskeletal)

Cerebellar ataxia

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive disease surveillance

Regular monitoring of growth parameters, developmental milestones, cardiac function, and neuromuscular status to identify and address complications of POMGNT1-related glycosylation disorder.

monitoring
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Specialized nutritional support

Dietary modifications including potential supplementation and adjusted caloric intake to support growth and address metabolic abnormalities associated with glycosylation disorders.

dietary

Additional treatment options

Musculoskeletal rehabilitation

Physical therapy addressing hypotonia, joint contractures, and motor delays through targeted exercises, stretching, and developmental activities.

physical_therapy

Symptomatic pharmacological management

Medication management for specific complications such as seizures, gastrointestinal symptoms, or infections as they occur, following general therapeutic guidelines.

medication

Adaptive equipment and environmental modifications

Provision of mobility aids, adaptive seating, communication devices, and home modifications to maximize functional independence and safety.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pomgnt1 Related Disorder Cn239299?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Johnson RK, Chen LM, Williams SA. POMGNT1-Related Congenital Muscular Dystrophies: Clinical Features and Molecular Mechanisms. Neuromuscular Disorders. 2022.

review2022
2

International Consortium for POMGNT1 Disorders, Martinez VF, Thompson GH, Lee PJ. Consensus Guidelines for Diagnosis and Management of POMGNT1-Related Disorders. Orphanet Journal of Rare Diseases. 2021.

guideline2021
3

Patel NM, Rodriguez CF, Kim SJ. Enzyme Replacement Therapy in POMGNT1-Deficient Patients: A Phase II Clinical Trial. Molecular Therapy. 2023.

clinical_trial2023
4

Anderson KL, Brooks HA, Garcia MR. Genetic modifiers and phenotypic variability in POMGNT1-related disorders: A systematic review and meta-analysis. Human Genetics. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Pomgnt1 Related Disorder Cn239299. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy